Description of the Psychiatric Care Pathway of Pregnant Women After the Early Prenatal Interview

October 5, 2020 updated by: University Hospital, Montpellier

Early Prenatal Interview : Throwback to the Hospital of Montpellier's Experience and Description of the Psychiatric Care Pathway of Pregnant Women.

Pregnancy and postpartum are recognized as periods of psychic fragility. However, the psychiatric disorders of women that can emerge during these periods are underdiagnosed and have consequences in particular on the development of the child, his relationship with his parents.

The need for an early diagnosis to allow appropriate treatment seems to be essential.

The pregnancy monitoring is centered on the somatic and little on psychological evaluation of the mother and the father.

In this context, the Early Prenatal Interview (EPP) was created through the perinatal plan of 2005-2007 in order to allow a more precise research of the factors of vulnerabilities likely to be predictive of a somatic, psychological or social disorder.

However, until now, only few pregnant women benefited of this interview. In May 2020, EPP became mandatory for all pregnant women. It now seems important to clearly identify the place, function, organization and usefulness of this interview in order to maximize its benefit in the monitoring of pregnancy

Study Overview

Status

Completed

Detailed Description

First, the investigators will describe the care pathway for pregnant women who have benefited of an early prenatal interview (EPP) between March 2019 and March 2020, namely continued classic follow-up or referral to a child psychiatrist / psychiatrist.

Then, the investigators will define two subgroups within the women oriented towards psychiatric follow-up: those who had this follow-up and those who did not.

Then, the investigators will identify the factors of failure of this referral to psychiatric follow-up and describe the eventual difficulties encountered by the lack of this follow-up.

Finally, the investigators will try to study these observations made with the perspective of maximizing the benefit of the Early Prenatal Interview in the monitoring of pregnancy.

Study Type

Observational

Enrollment (Actual)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Montpellier, France, 34295
        • Uhmontpellier

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Pregnant women who had an EPP at Montpellier's hospital between March 2019 and March 2020.

Description

Inclusion criteria:

  • No opposition from women to participate in the study
  • Women over 18
  • Women who had an EPP at Montpellier University Hospital between March 2019 and March 2020

Exclusion criteria:

- age < 18 years

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Retrospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of pregnant women who have been oriented to a psychiatric follow-up after EPP.
Time Frame: 1 day
Percentage of pregnant women who have been oriented to a psychiatric follow-up after EPP.
1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Description of the psychiatric care path after Early Prenatal Interview
Time Frame: 1 day

Description of the psychiatric care path after Early Prenatal Interview so :

  • percentage of pregnant women who were referred to a midwife
  • percentage of pregnant women who were referred to a child psychiatrist
  • percentage of pregnant women who were referred to an adult psychiatrist
  • percentage of pregnant women who were referred to an other follow-up
1 day
Identification of potential factors of failure.
Time Frame: 1 day
Identification of potential factors of failure : In the number of women who were referral to a child psychiatrist / psychiatrist, search the number of women who didn't see the child or adult psychiatrist and try to identify why for each of these women
1 day
Number of Participants with difficulties caused by the lack of follow-up
Time Frame: 1 day

Number of Participants with difficulties caused by the lack of follow-up as :

Search for each women who were referral to a child or adult psychiatrist ;

  • mode of delivery and term
  • complications of delivery for the baby or mother
  • hospitalization in psychiatry
  • prolongation of stay in the maternity Then compare for these criterias in women who see the child or adult psychiatrist or women who didn't see him and see if the difficulties are more present in women who didn't have the follow-up
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Pauline AVIT, resident, University Hospital, Montpellier

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2019

Primary Completion (Actual)

March 1, 2020

Study Completion (Actual)

March 30, 2020

Study Registration Dates

First Submitted

September 11, 2020

First Submitted That Met QC Criteria

September 28, 2020

First Posted (Actual)

October 5, 2020

Study Record Updates

Last Update Posted (Actual)

October 6, 2020

Last Update Submitted That Met QC Criteria

October 5, 2020

Last Verified

September 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

IPD Plan Description

NC

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Psychiatric Disorder

Subscribe